175 related articles for article (PubMed ID: 14980339)
1. Acute, transient urinary retention from combined ecstasy and methamphetamine use.
Delgado JH; Caruso MJ; Waksman JC; Honigman B; Stillman D
J Emerg Med; 2004 Feb; 26(2):173-5. PubMed ID: 14980339
[TBL] [Abstract][Full Text] [Related]
2. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
3. Neurogenic bladder and chronic urinary retention associated with MDMA abuse.
Beuerle JR; Barrueto F
J Med Toxicol; 2008 Jun; 4(2):106-8. PubMed ID: 18570171
[TBL] [Abstract][Full Text] [Related]
4. Shedding new light on the "safe" club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities.
Patel MM; Wright DW; Ratcliff JJ; Miller MA
Acad Emerg Med; 2004 Feb; 11(2):208-10. PubMed ID: 14759969
[TBL] [Abstract][Full Text] [Related]
5. [Case report: acute poisoning with ecstasy].
Franceschini E; Baronti R; Spaggiari C
Minerva Pediatr; 2000 Oct; 52(10):547-8. PubMed ID: 11144740
[No Abstract] [Full Text] [Related]
6. Alcohol and ecstasy (MDMA-3,4-methylenedioxymethamphetamine) overdose as a reason for acute hepatitis with gall bladder inflammation.
Mikuła T; Kozłowska J; Wiercińska-Drapało A
Drug Alcohol Rev; 2009 Nov; 28(6):685. PubMed ID: 19930025
[No Abstract] [Full Text] [Related]
7. Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats.
Kobeissy FH; Jeung JA; Warren MW; Geier JE; Gold MS
Addict Biol; 2008 Mar; 13(1):15-25. PubMed ID: 17910739
[TBL] [Abstract][Full Text] [Related]
8. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.
Brière FN; Fallu JS; Janosz M; Pagani LS
J Epidemiol Community Health; 2012 Nov; 66(11):990-4. PubMed ID: 22516739
[TBL] [Abstract][Full Text] [Related]
9. Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
Kaye S; Darke S; Duflou J
Drug Alcohol Depend; 2009 Oct; 104(3):254-61. PubMed ID: 19604654
[TBL] [Abstract][Full Text] [Related]
10. Widespread oral and oropharyngeal mucosal oedema induced by ecstasy (MDMA): A case for concern.
Ahmed M; Islam S; Hoffman GR
Br J Oral Maxillofac Surg; 2007 Sep; 45(6):496-8. PubMed ID: 17559993
[TBL] [Abstract][Full Text] [Related]
11. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study.
Patel MM; Belson MG; Wright D; Lu H; Heninger M; Miller MA
Resuscitation; 2005 Aug; 66(2):197-202. PubMed ID: 15963623
[TBL] [Abstract][Full Text] [Related]
12. Effects of motivational enhancement therapy on readiness to change MDMA and methamphetamine use behaviors in Taiwanese adolescents.
Huang YS; Tang TC; Lin CH; Yen CF
Subst Use Misuse; 2011; 46(4):411-6. PubMed ID: 20735217
[TBL] [Abstract][Full Text] [Related]
13. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic.
Urbina A; Jones K
Clin Infect Dis; 2004 Mar; 38(6):890-4. PubMed ID: 14999636
[TBL] [Abstract][Full Text] [Related]
14. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
Falck RS; Wang J; Carlson RG
J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
[TBL] [Abstract][Full Text] [Related]
15. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
16. 3 cases of primary intracranial hemorrhage associated with "Molly", a purified form of 3,4-methylenedioxymethamphetamine (MDMA).
Kahn DE; Ferraro N; Benveniste RJ
J Neurol Sci; 2012 Dec; 323(1-2):257-60. PubMed ID: 22998806
[TBL] [Abstract][Full Text] [Related]
17. Urinary retention due to clonazepam in a child with dyskinetic cerebral palsy.
Caksen H; Odabaş D
J Emerg Med; 2004 Feb; 26(2):244. PubMed ID: 14980361
[No Abstract] [Full Text] [Related]
18. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
19. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
20. [Visits to the emergency department due to ecstasy (MDMA) and amphetamine derivative consumption: Epidemiological, clinical and evolutional profile].
Galicia M; Nogué S; Sanjurjo E; Miró O
Rev Clin Esp; 2010 Sep; 210(8):371-8. PubMed ID: 20673888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]